Southampton, United Kingdom

Ali Tavassoli

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 1.3

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Ali Tavassoli

Introduction

Ali Tavassoli is a prominent inventor based in Southampton, GB. He has made significant contributions to the field of peptide libraries and inhibitors, holding a total of three patents. His work focuses on innovative methods that have the potential to impact various scientific and medical applications.

Latest Patents

Tavassoli's latest patents include methods for generating and screening compartmentalised peptide libraries. This method involves co-compartmentalising a cyclic polypeptide with a polynucleotide encoding the cyclic polypeptide. The process includes forming a compartment containing the polynucleotide, expressing a polypeptide from it, and cyclising the polypeptide. Additionally, he has developed co-compartmentalised cyclic polypeptides and encoding polynucleotides, along with methods for screening these libraries. Another significant patent relates to HIF-1 and HIF-2 inhibitors, which are crucial for treating various diseases. This invention provides an isolated polypeptide that prevents dimerization of HIF-1α with HIF-1β and HIF-2α with HIF-1β, thereby inhibiting the activity of HIF-1 and HIF-2.

Career Highlights

Ali Tavassoli is affiliated with the University of Southampton, where he conducts his research and development. His work has garnered attention for its innovative approach to peptide libraries and their applications in medicine.

Collaborations

Some of his notable coworkers include Catrin Sohrabi and Martin Fischlechner, who contribute to the collaborative research efforts at the University of Southampton.

Conclusion

Ali Tavassoli's innovative work in the field of peptide libraries and inhibitors showcases his significant contributions to science and medicine. His patents reflect a commitment to advancing research that can lead to new treatments for diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…